Gillette
This article was originally published in The Rose Sheet
Executive Summary
Blades and Razors sales advanced 11% to $1.21 bil. on a reported basis, and profit from operations in the unit increased 16% to $488 mil. in the second quarter, Gillette announces Aug. 4. Results were boosted in part by a double-digit sales increase in North America for the Venus women's shaving brand, which benefited from the launch of Venus Vibrance and new Venus Disposable razor. Gillette's global value share of the blades/razors segment increased by more than one percentage point to 71.5%, while M3Power remained the top-selling men's razor in North America and worldwide with a 19% value share, according to the firm. Personal care sales were up 9% to $256 mil., with profit from operations advancing 25% to $30 mil., reflecting improved product mix and "ongoing trade-up from shaving foams to gels," company notes. Net sales rose 13.4% to $2.77 bil., while net income increased 16.9% to $498 mil...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.